Lack of assurance of sterility: Lack of validation data for sanitization cycles
Status
Terminated
Classification
Class II
Report Date
August 9, 2023
Termination Date
March 21, 2025
Product Information
Product description
HYDROmorphone in Dextrose 5%, 0.5 mg/5 mL (0.1 mg/mL), 5 mL Syringe, Rx only, CAPS, Inc., 7935 Dunbrook Road, Suite C, San Diego, CA 92126, NDC 71286-2013-1
Product quantity
1,389 syringes
Reason for recall
Lack of assurance of sterility: Lack of validation data for sanitization cycles